References
1. Pokrovsky A.V., Ivandaev A.S. Status of vascular sur- gery in Russia in 2014. Moscow, 2015: 101 p. (in Russian).
2. Pokrovsky A.V., Ivandaev A.S. Status of Vascular Sur- gery in Russia in 2016. Moscow, 2017: 76 p. (in Russian).
3. Becker F., Robert E.H., Ricco J.B., et al. Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011; 42 (2 Suppl): 4–12. doi: 10.1016/S1078-5884(11)60009-9.
4. Pokrovsky A.V. Diseases of the aorta and its branches. Moscow: Meditsina, 1979: 324 p. (in Russian).
5. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997; 26: 517–38.
6. Reinecke H., Unrath M., Freisinger E., Bunzemeier H., et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015; 36 (15): 932–8. doi: 10.1093/eurheartj/ehv006.
7. Abu Dabrh A.M., Steffen M.W., Undavalli C., et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015; 62 (6): 1642–51. doi: 10.1016/j.jvs.2015.07.065.
8. Gavrilenko A.V., Kotov A.E., Kochetov S.V. Influence of the pathogenic flora on the results of surgical treatment in patients with IV degree critical limb ischemia infrainguinal disease. Annaly khirurgii [Annals of Surgery]. 2017; 22 (1): 29–35. (in Russian).
9. Quilici M.T., Del F.S., Vieira A.E., Toledo M.I. Risk factors for foot amputation in patients hospitalized for diabetic foot infection. J Diabetes Res. 2016; 2016: 8931508. doi: 10.1155/2016/8931508.
10. Armstrong D.G, Mills J.L. Juggling risk to reduce amputations: the three-ring circus of infection, ischemia and tissue loss-dominant conditions. Wound Med. 2013; 1: 13–14. doi: 10.1016/j.wndm.2013.03.002.
11. Roth-Albin I., Mai S.H., Ahmed Z., et al. Outcomes following advanced wound care for diabetic foot ulcers: a Canadian study. Can J Diabetes. 2017; 41: 26–32. doi: 10.1016/j.jcjd.2016.06.007.
12. Mills J.L., Conte M.S., Armstrong D.G., et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014; 59 (1): 220–34. doi: 10.1016/j.jvs.2013.08.003.
13. Cull D.L., Manos G., Hartley M.C., et al. An early validation of the Society for vascular surgery lower extremity threatened limb classification system. J Vasc Surg. 2014; 60 (6): 1535–42. doi: 10.1016/j.jvs.2014.08.107.
14. Zhan L.X., Branco B.C., Armstrong D.G., Mills J.L. The Society for Vascular Surgery (SVS) lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIFI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015; 61: 939–44. doi: 10.1016/j.jvs.2014.11.045.
15. Beropoulis E., Stavroulakis K., Schwindt A., et al. Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg. 2016; 64: 95–103. doi: 10.1016/j.jvs.2016.01.040.
16. Darling J.D., McCallum J.C., Soden P.A., et al. Predictive ability of the SVS WIfI classification system following infrapopliteal endovascular interventions for CLI. J Vasc Surg. 2016; 64 (3): 616–22. doi: 10.1016/j.jvs.2016.03.417.
17. van Haelst S.T.W., Teraa M., Moll F.L., et al. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIFI) classification in patients with no-option chronic limb-threatening ischemia. J Vasc Surg. 2018; 68: 1–10. doi: 10.1016/j.jvs.2018.02.028
18. Fossaceca R., Guzzardi G., Cerini P., et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective? Cardiovasc Intervent Radiol. 2013; 36: 637–44. doi: 10.1007/s00270-012-0544-4.
19. Kabra A., Suresh K.R., Vivekanand V., et al. Out- comes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg. 2013; 57 (1): 44–9. doi: 10.1016/j.jvs.2012.07.042.
20. Conte M.S., Bandyk D.F., Clowes A.W., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006; 43: 742–51. doi: 10.1016/j.jvs.2005.12.058.
21. Kumar A., Brooks S.S., Cavanaugh K., Zuckerman B. FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009; 50 (5): 1474–6. doi: 10.1016/j.jvs.2009.09.045.
22. Norgren L., Hiatt W., Dormandy J., et al. Inter- society consensus for the management of peripheral arterial disease. J Vasc Surg. 2007; 45 (1 Suppl): 5–67. doi: 10.1016/j.jvs.2006.12.037.
23. Leithead C., Novak Z., Spangler E., et al. Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI) restaging in predicting limb salvage. J Vasc Surg. 2018; 67 (2): 498–505. doi: 10.1016/j.jvs.2017.07.109.
24. Morin J., Lakhlif E., Midy D., et al. Evaluaton of femoro-popliteal angioplastes with the need for retrograde approach in a twin center series of 26 consecutve cases. J Vasc Endovasc Surg. 2016; 1 (4): 1–10. doi: 10.21767/2573-4482.100029.
25. Darling J.D., McCallum J.C., Soden P.A., et al. Predictive ability of the SVS WIfI classification system following first-time lower extremity revascularizations. J Vasc Surg. 2017; 65 (3): 695–704. doi: 10.1016/j.jvs.2016.09.055.
26. Causey M.W., Ahmed A., Wu B., et al. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016; 63 (6): 1563–73. doi: 10.1016/j.jvs.2016.01.011.
27. Robinson W.P., Loretz L., Hanesian C., et al. Society for Vascular Surgery Wound, Ischemia, foot In- fection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg. 2017; 66 (2): 488–98. doi: 10.1016/j.jvs.2017.01.063.